These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12873865)

  • 1. Cognitive decline in Down syndrome.
    Margallo-Lana ML; Ballard C; Morris C; Kay D; Tyrer S; Moore B
    Arch Neurol; 2003 Jul; 60(7):1024; author reply 1024. PubMed ID: 12873865
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 3. Mild cognitive impairment and dementia.
    Albert MS; Blacker D
    Annu Rev Clin Psychol; 2006; 2():379-88. PubMed ID: 17716075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors in the treatment of dementia.
    Margallo-Lana ML; Ballard C; Morris C; Kay D; Tyrer S; Moore B
    Int J Geriatr Psychiatry; 2003 May; 18(5):458-9. PubMed ID: 12766925
    [No Abstract]   [Full Text] [Related]  

  • 5. Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil.
    Kondoh T; Amamoto N; Doi T; Hamada H; Ogawa Y; Nakashima M; Sasaki H; Aikawa K; Tanaka T; Aoki M; Harada J; Moriuchi H
    Ann Pharmacother; 2005 Mar; 39(3):563-6. PubMed ID: 15701776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

  • 8. Donepezil for cognitive deficits following traumatic brain injury: a case report.
    Bourgeois JA; Bahadur N; Minjares S
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):463-4. PubMed ID: 12426418
    [No Abstract]   [Full Text] [Related]  

  • 9. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
    Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC
    Cogn Neuropsychiatry; 2007 Sep; 12(5):412-21. PubMed ID: 17690999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI.
    Salloway S; Correia S; Richardson S
    Int Psychogeriatr; 2008 Feb; 20(1):40-6. PubMed ID: 17597552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB).
    Sinai A; Hassiotis A; Rantell K; Strydom A
    PLoS One; 2016; 11(5):e0153917. PubMed ID: 27171413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
    Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D
    Int Psychogeriatr; 2008 Apr; 20(2):259-92. PubMed ID: 18252031
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholinergic therapy for Down's syndrome.
    Kishnani PS; Sullivan JA; Walter BK; Spiridigliozzi GA; Doraiswamy PM; Krishnan KR
    Lancet; 1999 Mar; 353(9158):1064-5. PubMed ID: 10199357
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
    Rueda N; Flórez J; Martínez-Cué C
    Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When the drugs don't work.
    Logan A
    Br J Gen Pract; 2005 Aug; 55(517):639. PubMed ID: 16105378
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil use in Down syndrome.
    Kishnani PS; Sullivan JA; Spiridigliozzi GA; Heller JH; Crissman BG
    Arch Neurol; 2004 Apr; 61(4):605-6. PubMed ID: 15096417
    [No Abstract]   [Full Text] [Related]  

  • 18. Donepezil treatment of topiramate-related cognitive dysfunction.
    Wheeler SD
    Headache; 2006 Feb; 46(2):332-5. PubMed ID: 16492246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mild Cognitive Impairment: potential therapeutics].
    Allain H; Bentue-Ferrer D; Belliard S; Reymann JM; Djemaï M; Merienne M
    Rev Neurol (Paris); 2002; 158(10 Suppl):S35-40. PubMed ID: 12529584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advertisements for donepezil. National policy needs to be set for prescribing of this drug.
    Boothby H; Zaidi SM; Seth V; Khalaf S; Jameel H; Mahomed S; al-Yassiri
    BMJ; 1997 Dec; 315(7122):1624. PubMed ID: 9437305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.